Table 1 Clinical and demographic characteristics of our patients (N = 35)

Age (years)

52

90

70.4

9.2

Diabetes duration (years)

5

28

17.4

7.1

Insulin treatment duration (years)

2

19

7.6

3.4

Fasting BG (mmol/l (mg/dl))

2.4 (43.2)

16.7 (300.6)

8.0 (144)

2.5 (45)

HbA1c (mmol/mol (%))

44.3 (6.2)

74.9 (9.0)

57.4 (7.4)

5.4 (0.7)

Body weight (kg)

61

115

84.6

14.4

Body mass index (kg/m2)

24

46

31.3

5.1

Waist circumference (cm)

85

132

110

12

Daily total insulin dose (units)

24

78

46.4

12.1

Daily insulin doses (number/day)

2

3

2.2

0.4

CGM active sensor data (days)

6

11

9.6

1

Relative body weight change in the previous 5 years (%)

− 6

8

1.8

3.6

Female sex

18

51

Premixed insulin

Aspart 30: 28

Lispro 25: 7

80

20

Metformin therapy

24

69

SGLT2 inhibitor therapy

11

31

DPP-4 inhibitor therapy

6

17

GLP-1 receptor agonist therapy

2

6

Insulin secretagogues therapy

0

0

HbA1c (mmol/mol (%))

To 53 (7.0): 9

53 (7.0)–69.4 (8.5): 19

69.4 (8.5) + : 7

26

54

20

At least 1 microvascular complication of diabetes

24

69

At least one macrovascular complication of diabetes

13

37